COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases.

Autor:	Santana FM; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Rezende RPV; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.; Universidade Federal Fluminense, Divisão de Reumatologia, Departamento de Medicina Clínica (MMC), Niterói, Rio de Janeiro, Brazil., Paschoal NOS; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Rocha LF; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Lopes JB; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Perez MO; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Bunjes BG; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Dório M; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.; Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Furquim MAD; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.; Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Cobra JF; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil., Sales LP; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.; Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Figueiredo CP; Instituto de Reumatologia de São Paulo, São Paulo, São Paulo, Brazil.; Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Jazyk:	angličtina
Zdroj:	Public health in practice (Oxford, England) [Public Health Pract (Oxf)] 2023 Aug 09; Vol. 6, pp. 100419. Date of Electronic Publication: 2023 Aug 09 (Print Publication: 2023).
DOI:	10.1016/j.puhip.2023.100419
Abstrakt:	Objective: Assess the perceived protection afforded by a range of COVID-19 vaccines in immune-mediated inflammatory diseases patients previously vaccinated against SARS-CoV-2. Study Design: Survey. Methods: On-line cross-sectional survey aimed at evaluating the perceived protection (and its determinants) afforded by a range of COVID-19 vaccines among immune-mediated inflammatory diseases previously vaccinated for COVID-19. Results: Out of 493 eligible respondents who lived in Brazil, 397 (80.5%) were confident that their primary vaccination series would protect them against severe COVID-19. In multivariate analysis, only overlapping immune-mediated inflammatory diseases remained (negatively) associated with the perception of protection. Conclusions: No influence was found between COVID-19 vaccine types and the perception of protection after initial vaccinations. Competing Interests: The authors declare that there is no conflict of interest.The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2023 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu